Search

Author/Creator Di Simone, Christopher

1. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018). Issue 1 (13th February 2019)

Authors:
Berry, Sneha; Giraldo, Nicolas; Nguyen, Peter; Green, Benjamin; Xu, Haiying; Ogurtsova, Aleksandra; Soni, Abha; Succaria, Farah; Wang, Daphne; Roberts, Charles; Stein, Julie; Engle, Elizabeth; Pardoll, Drew; Anders, Robert; Cottrell, Tricia; Taube, Janis M.; Tran, Ben; Voskoboynik, Mark; Kuo, Jam...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial. Issue 5 (May 2019)

Authors:
Makker, Vicky; Rasco, Drew; Vogelzang, Nicholas J; Brose, Marcia S; Cohn, Allen L; Mier, James; Di Simone, Christopher; Hyman, David M; Stepan, Daniel E; Dutcus, Corina E; Schmidt, Emmett V; Guo, Matthew; Sachdev, Pallavi; Shumaker, Robert; Aghajanian, Carol; Taylor, Matthew
Journal:
Lancet oncology
Issue:
Volume 20:Issue 5(2019)
Page Start:
711
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. Issue 7 (July 2021)

Authors:
Lee, Chung-Han; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Kroh...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
946
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗